首页>
外国专利>
BIOMARKER COMPOSITION FOR PREDICTING RESPONSE OF CERVICAL CANCER PATIENT TO CHEMORADIOTHERAPY
BIOMARKER COMPOSITION FOR PREDICTING RESPONSE OF CERVICAL CANCER PATIENT TO CHEMORADIOTHERAPY
展开▼
机译：用于预测宫颈癌患者对化学疗法的生物标志物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a biomarker composition for predicting the response of a cervical cancer patient to chemoradiotherapy and, specifically, provides a biomarker composition for predicting the response of a cervical cancer patient to chemoradiotherapy, the composition comprising, as an active ingredient, any one or more RNAs selected from the group consisting of has-miR-150-3p mRNA and PR/SET domain 1 (PRDM1) mRNA. By using the biomarker composition, it is possible to more effectively and easily predict the response of a cervical cancer patient to chemoradiotherapy through a relative change in an RNA expression level. In addition, by providing appropriate treatment for symptoms through the prediction of a response to the therapy, unnecessary treatment is avoided and therapeutic effects can be improved through patient-specific treatment.
展开▼
